Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan D Voss

Showing results (81-90 of 105) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodSurya P Rednam, Ayelet Erez, Harriet Druker, et al.
The Lancet. Oncology|April 20, 2013
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium studyYael P Mossé, Megan S Lim, Stephan D Voss, et al.
Pediatric Blood & Cancer|July 17, 2020
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) groupJennifer Seelisch, Pedro A De Alarcon, Jamie E Flerlage, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 TrialXin Tie, Changhee Lee, Scott B Perlman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupSuman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2007
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugatesStephan D Voss, Suzanne V Smith, Nadine DiBartolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Pageof 11

Showing results (81-90 of 105) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2017
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in ChildhoodSurya P Rednam, Ayelet Erez, Harriet Druker, et al.
The Lancet. Oncology|April 20, 2013
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium studyYael P Mossé, Megan S Lim, Stephan D Voss, et al.
Pediatric Blood & Cancer|July 17, 2020
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) groupJennifer Seelisch, Pedro A De Alarcon, Jamie E Flerlage, et al.
Pediatric Blood & Cancer|May 18, 2023
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology GroupKeri A Streby, Marguerite T Parisi, Barry L Shulkin, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Evaluation of Baseline and Interim-Therapy PET Features for Prognostication in High-Risk Pediatric Hodgkin Lymphoma: A Retrospective Analysis of the AHOD1331 TrialXin Tie, Changhee Lee, Scott B Perlman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2019
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312)Kristina A Cole, Sharmistha Pal, Rachel A Kudgus, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology GroupSuman Malempati, Brenda Weigel, Ashish M Ingle, et al.
Radiology|January 21, 2025
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL)Dietrich Stoevesandt, Jonas Steglich, Jörg M Bartelt, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 24, 2007
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugatesStephan D Voss, Suzanne V Smith, Nadine DiBartolo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2019
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921)Yael P Mossé, Elizabeth Fox, David T Teachey, et al.
Pageof 11